The aims of this study were to determine whether assumptions used in prenatal screening for Down syndrome in twin pregnancies are valid and derive estimates of risk and screening performance in twin pregnancies using observed data. Data were collected on nuchal translucency, chorionicity, pregnancy associated plasma protein-A (PAPP-A), and free ß human chorionic gonadotrophin (free ß-hCG) from 61 twin pregnancies with Down syndrome and 7302 unaffected twin pregnancies. Distribution parameters were determined and used to estimate screening performance. The assumption that proportional differences in serum marker levels in affected and unaffected singleton pregnancies apply to twin pregnancies was not confirmed. Median free β-hCG value in monochorionic affected twin pregnancies (2.63 multiples of the median [MoM]; 95% CI, 1.79-3.22 MoM) was lower than that assuming proportionality (3.76 MoM), and the median PAPP-A value in dichorionic affected twin pregnancies (1.88 MoM; 95% CI, 1.60-2.17 MoM) was higher than that based on proportionality (1.33 MoM). The detection rate was 87% for a 3% false-positive rate in monochorionic twin pregnancies and 74% in dichorionic twin pregnancies compared with 86% in singleton pregnancies. Estimates of screening performance in Down syndrome twin pregnancies do not need to rely on assumptions and can take account of chorionicity and gestational age.
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| INTRODUCTION
Prenatal screening for Down syndrome is more complex in twin pregnancies than in singleton pregnancies. Because of a lack of data on twin pregnancies with Down syndrome, estimates of the risk of having an affected twin pregnancy have relied on the assumption that the proportional differences in serum marker levels in affected and unaffected singleton pregnancies can be applied to levels found in twin pregnancies, which tend to be about twice as high. 1 On this basis, the median marker level in affected monochorionic twin pregnancies is taken as the median level in affected singleton pregnancies multiplied by the median level in unaffected twin pregnancies. Similarly, the median marker level in dichorionic twins is taken as the average of the medians in unaffected and affected singleton pregnancies, multiplied by the median in unaffected twin pregnancies. 1 With marker levels expressed as multiple of the median (MoM) in unaffected singleton pregnancies (MoM), and based on these assumptions, the median late first-trimester pregnancy associated plasma protein-A (PAPP-A) and free β-human chorionic gonadotrophin (hCG) levels have been estimated to be 0.80 and 3.76 MoM, respectively, in monochorionic affected twin pregnancies and 1.33 and 2.93 MoM in dichorionic affected twin pregnancies, respectively. 1 The assumptions on which these estimates are based have not been empirically tested.
We here do so using data from five screening centres.
Nicholas Wald and Jonathan Bestwick are joint first authors. For each simulated monochorionic twin pregnancy, the risk of being affected with Down syndrome at term was calculated by multiplying the maternal age specific odds of having an affected singleton live birth, 5 adjusted by the 66% reduction in risk of a pregnancy being affected if it is a monochorionic twin pregnancy compared with a singleton pregnancy, 6 by the likelihood ratio for being affected (for the simulated set of marker values) calculated from the multivariate Gaussian distributions of marker levels in affected and unaffected pregnancies. For each simulated dichorionic twin pregnancy, the risk of being affected with Down syndrome at term was calculated by multiplying half the maternal age specific odds of having an affected singleton live birth, 5 adjusted by the 34% increase in risk of at least one of the fetuses being affected in a dichorionic twin pregnancy compared with a singleton pregnancy, 6 by the likelihood ratio for each NT MoM value, summing the two and then multiplying that by the likelihood ratio for the serum markers. Risks were also calculated based on using NT alone, with maternal age. Screening performance was estimated as detection rates (DRs) for specified false-positive rates (FPRs), FPRs for specified DRs, and DRs and FPRs for specified risk cut-offs. Screening performance in twin pregnancies was compared with that in singleton pregnancies using updated parameters from the Serum, Urine, and Ultrasound Screening Study (SURUSS) 
| METHODS
7
What's already known about this topic?
• Prenatal Down syndrome screening markers in unaffected twin pregnancies are approximately double those in singleton pregnancies.
• It has generally been assumed that the proportional differences in serum marker levels in affected and unaffected singleton pregnancies can be applied to levels found in twin affected and unaffected pregnancies.
What does this study add?
• The median late first-trimester free β-hCG level in monochorionic affected twin pregnancies is lower than levels based on the proportionality assumption, and the median PAPP-A level in dichorionic affected twin pregnancies is higher.
• Combined test screening performance in monochorionic twins is similar to that in singletons, but lower in dichorionic twins.
• Different combined test risk cut-offs in monochorionic and dichorionic twin pregnancies would be needed to achieve similar false-positive rates. 13 9 ; among 22 706 unaffected pregnancies, the log 10 standard deviation was 0.0963 in pregnancies screened in the 11th week of pregnancy and 0.0843 between 12 and 13 weeks, lower than the values we previously reported (0.1275 and 0.1105, respectively). 2 The lower standard deviation of 0.0843 was used in estimating screening performance in singleton pregnancies.
3 | RESULTS b In one dichorionic pregnancy, one twin was affected with Down syndrome, and the other twin was affected with trisomy 13. The NT from the fetus with trisomy 13 was not included in calculation of the median NT. Table 2 shows the parameters used to estimate risks and screening performance. Figure 3 shows the detection rates for a 3% false-positive rate using NT alone with maternal age and the combined test (which includes maternal age) in singleton pregnancies, monochorionic twin pregnancies, and in dichorionic twin pregnancies. In singleton pregnancies, the addition of the serum markers to NT increased the detection rate by 10 percentage points (from 76% to 86%), by 13 FIGURE 2 Median free β-hCG and PAPP-A multiple of the median values for unaffected twin pregnancies in affected twin pregnancies according to chorionicity and gestational age together with overall medians (horizontal lines)
percentage points in monochorionic twin pregnancies (from 74% to 87%), and by 4 percentage points in dichorionic twin pregnancies (from 70% to 74%). Table 3 shows estimates of screening performance for five specified false-positive rates and five specified detection rates.
For example, the detection rate at a 3% false-positive rate was, respectively, 87% and 74% for monochorionic and dichorionic twin pregnancies. Table 4 shows detection rates and false-positive rates for a range of term risk cut-offs. For example, at a 1 in 150 risk cutoff, the screening performance is 77% for a 0.6% false-positive rate in monochorionic twin pregnancies and 81% for a 6.4% false-positive rate in dichorionic twin pregnancies. The detection rates and the falsepositive rates at a given risk cut-off are higher in dichorionic twin pregnancies than in monochorionic twin pregnancies. Table 5 shows the (rounded) risk cut-offs in singleton pregnancies and monochorionic and dichorionic twin pregnancies that could be used to achieve the same false-positive rates. For example, at a 2% false-positive rate, a risk cut-off of 1 in 150 could be used for singleton pregnancies, 1 in 500 for monochorionic twin pregnancies, and 1 in 60 for dichorionic twin pregnancies.
| DISCUSSION
Our results show that the assumption that the pattern of marker levels seen in affected and unaffected singleton pregnancies will be proportionately the same in twin pregnancies is not the case. The median PAPP-A value in dichorionic affected twin pregnancies was lower than in unaffected twin pregnancies (0.79 times lower, Table 2 ) but not as low as in affected singleton pregnancies compared with unaffected singleton pregnancies (0.50 at 12 weeks' gestation). 8 Also, the median free β-hCG level in affected twin pregnancies (monochorionic and dichorionic twin pregnancies combined) was higher than in unaffected twin pregnancies (1.43 times higher, Table 2 ) but not as high as in affected singleton pregnancies compared with unaffected singleton pregnancies (2.19 at 12 weeks' gestation). 8 In monochorionic twin pregnancies, screening performance is similar to that in singleton pregnancies. In dichorionic pregnancies, the discrimination of PAPP-A and free β-hCG between affected and unaffected pregnancies is lower than that in singleton pregnancies. This means that screening performance in dichorionic twin pregnancies using the combined test is less than has been previously estimated, 7 but still improved over using NT and maternal age alone. All monochorionic twins are monozygotic (identical), so averaging NT 
The correlation between free β-hCG and PAPP-A log 10 MoM T values in unaffected twin pregnancies was 0.1790; the correlation coefficient between paired log 10 NT MoM T values in unaffected dichorinic twin pregnancies was 0.4585; all other correlation coefficients were not statistically significant and taken as zero.
b There were no statistically significant change in free β-hCG or PAPP-A MoM T values with gestational age in affected twin pregnancies (P = 0.545 and P = 0.345, respectively). Similarly, there was no change in NT MoM T values in monochorionic or dichorionic affected twin pregnancies with gestational age (P = 0.703 and P = 0.701, respectively).
c No statistically significant difference between affected fetuses from monochorionic and dichorionic twin pregnancies so overall median and standard deviation taken (see Table 1 ).
d No statistically significant difference between monochorionic and dichorionic twin pregnancies (see Table 1 ).
e Truncation limit set at point of risk reversal.
FIGURE 3 Down syndrome detection rates for a 3% false-positive rate using nuchal translucency (NT) with maternal age or the combined test (CT), which includes maternal age, in singleton (12 completed weeks), monochorionic twin and dichorionic twin pregnancies values in monochorionic twins is valid; however, about 10% of dichorionic pregnancies are monozygous, 10 and in these cases, not averaging the NT measurements will introduce some error in relation to how NT is used in the screening algorithm. This, however, has a negligible effect on screening performance; among such pregnancies, the detection rate of NT alone with age is only 1 percentage point lower than that for dichorionic dizygous twin pregnancies at a 3% false-positive rate, with no change in the detection rate of the combined test. If chorionicity status is unknown, it would be reasonable to assume dichorionicity, as about 80% of twins are dichorionic.
Our results are in general consistent with those of Madsen et al. affected twins in our paper. Table 4 shows that for a given risk cut-off screening performance differs significantly between monochorionic and dichorionic twin pregnancies. This is mainly due to Down syndrome pregnancies being 66% less common in monochorionic twin pregnancies than in singleton pregnancies, but 34% more common in dichorionic than in singleton pregnancies, 6 which leads to a fourfold difference in the background maternal age-related risk between monochorionic and dichorionic twin pregnancies.
As an ultrasound scan is performed at 11 to 13 weeks to measure crown-rump length and NT, the chorionicity status can also be determined, and if chorionicity status in twin pregnancies is known, consideration could be given to the use of different risk cut-off levels in monochorionic and dichorionic twin pregnancies from those in singleton pregnancies to achieve a similar screening performance (see Table 5 ).
In summary, our results indicate that it is still appropriate to use PAPP-A and free β-hCG as well as nuchal translucency in screening twin pregnancies, but appropriate revisions are needed to update the distribution parameters for the screening markers.
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